The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.
 
Juanita Suzanne Lopez
Consulting or Advisory Role - Basilea; CureTeq; Ellipses Pharma; Genmab; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Astex Pharmaceuticals (Inst); Basilea (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Basilea; Roche/Genentech
 
Simon Haefliger
Consulting or Advisory Role - Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen
 
Ruth Plummer
Honoraria - Alligator Bioscience; GlaxoSmithKline; Sotio
Consulting or Advisory Role - Astex Pharmaceuticals; Bayer; Bristol-Myers Squibb; CV6 Therapeutics; Cybrexa Therapeutics; Ellipses Pharma; Genmab; Immunocore; Medivir; Novartis; Onxeo; Pierre Fabre; Sanofi/Aventis
Patents, Royalties, Other Intellectual Property - Clovis Oncology (Inst)
 
Paul M. Clement
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MSD Belgium BVBA (Inst); Orbus Therapeutics (Inst); Rakuten Medical (Inst); Takeda (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst)
 
Heinz Philipp Laubli
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
Research Funding - Anaveon; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlycoEra; Palleon Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck/Schering Plough; Roche
 
Patrick Roth
Honoraria - Merck; Novocure; Roche
Consulting or Advisory Role - Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Midatech Pharma; MSD; QED Therapeutics
Research Funding - MSD (Inst); Novocure (Inst)
 
T.R. Jeffry Evans
Honoraria - Ascelia (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); Bristol Myers Squibb (Inst); Eisai (Inst); Medivir (Inst); Merck Sharp & Dohme (Inst); Nucana (Inst); Roche/Genentech (Inst)
Consulting or Advisory Role - Karus Therapeutics (Inst)
Speakers' Bureau - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Eisai (Inst); Medivir (Inst); Merck Sharp & Dohme (Inst); Nucana (Inst); Roche/Genentech (Inst); United Medical (Inst)
Research Funding - Adaptimmune (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Athenex (Inst); Avacta Life Sciences (Inst); Basilea (Inst); Beigene (Inst); Berg Pharma (Inst); Bicycle Therapeutics (Inst); BiolineRx (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Codiak BioSciences (Inst); CytomX Therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Immunocore (Inst); iOnctura (Inst); Iovance Biotherapeutics (Inst); Janssen (Inst); Johnson & Johnson (Inst); Lilly (Inst); Medivir (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MiNA Therapeutics (Inst); Modulate Pharma (Inst); Novartis (Inst); Nucana (Inst); Nurix (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Sapience Therapeutics (Inst); Seagen (Inst); Sierra Pharma (Inst); Starpharma (Inst); T3 Pharmaceuticals (Inst); UCB (Inst); Verastem (Inst); Vertex (Inst)
Expert Testimony - Medivir (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb; Eisai; Merck Sharp & Dohme; Nucana; Pierre Fabre
Other Relationship - Genmab (Inst)
 
Lucy Brazil
No Relationships to Disclose
 
Ghazaleh Tabatabai
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis (Inst); Bayer Germany (Inst); Boehringer Ingelheim (Inst); CureVac (Inst)
 
Antje Wick
No Relationships to Disclose
 
Wing Hing Hing Yau
Travel, Accommodations, Expenses - Parexel
 
Benjamin Wunderlich
Employment - Discovery Life Sciences
 
Kirk Beebe
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
 
Joel Robert Eisner
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric; Innocrin Pharma
Consulting or Advisory Role - Propella Therapeutics
Patents, Royalties, Other Intellectual Property - Provisional patents for GeneCentric and Innocrin Pharma as part of my employments
 
Marc Engelhardt
Employment - Basilea Pharmaceutical
Leadership - Basilea Pharmaceutical
Stock and Other Ownership Interests - Basilea Pharmaceutical
Patents, Royalties, Other Intellectual Property - Basilea Pharmaceutical
 
Thomas Kaindl
Employment - Basilea Pharmaceutical
Stock and Other Ownership Interests - Basilea Pharmaceutical
 
Heidi A Lane
Employment - Basilea Pharmaceutical
Stock and Other Ownership Interests - Basilea Pharmaceutical
Patents, Royalties, Other Intellectual Property - Basilea Pharmaceutical
 
Peter Hau
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novocure
Speakers' Bureau - Lilly O.; Medac; Novocure; Seagen
Travel, Accommodations, Expenses - Medac; Novocure
Other Relationship - European Association of Neuro-Oncology; European Organisation for Research and Treatment of Cancer; Neuroonkologische Arbeitsgemeinschaft; Society for Neuro-Oncology
 
Thomas Hundsberger
Consulting or Advisory Role - Amicus Therapeutics; Bayer; Genzyme; Novocure; Sanofi
Research Funding - Bayer
Travel, Accommodations, Expenses - Amicus Therapeutics; Genzyme; Sanofi
 
Joachim Steinbach
Consulting or Advisory Role - Boehringer Ingelheim; Novocure; Roche; Seagan